May 12 (Reuters)-
Immuno Biological Laboratories Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2017 Mar 31, 2016 Mar 31, 2018 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 741 mln 717 mln 773 mln
(+3.3 pct) (-1.6 pct) (+4.2 pct)
Operating loss 1.16 loss 75 mln loss 116 mln
Recurring loss 1.17 loss 81 mln loss 122 mln
Net
Net loss 2.09 loss 31 mln loss 128 mln
EPS loss 287.52 yen loss 4.86 yen loss 17.25 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - Immuno Biological Laboratories Co Ltd.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T
((Tokyo Headline News Desk +813 6441 1812))